Week 3 (exam 2) Flashcards
Kidney disorders
Functions of the kidney
Acid-Base balance
Water removal
Erythropoiesis
Toxin removal
Blood pressure (ADH)(Vasopressin)
Electrolyte balance
Vi D activation
Chronic Kidney Disease
Umbrella term that describes decrease in kidney function lasting 3 or more months. Untreated leads to ESKD (end stage kidney disease)
Stages 1-5 of chronic kidney disease
Stage 1: GFR > 90
Stage 2: GFR 60 – 89
Stage 3: GFR 30 – 59
Stage 4: GFR 15 – 29
Stage 5: GFR < 15
Clinical manifestations of CKD
Increased creatinine levels
Anemia
Metabolic Acidosis
Fluid retention
Edema
Heart failure
Abnormal calcium and phosphorus levels.
Management of CKD
- Treat underlying cause
- Monitor labs (GFR), Creatinine clearance, BP and Weight
- Dialysis or early referral to RRT
Acute Kidney Injury
a rapid loss of renal function due to damage to the kidneys
if treated it can be reversed
Clinical manifestations of AKI
- critically ill and lethargic
- drowsiness
- headache
- muscle twitching
- seizures
- elevated BUN and creatine
- decline in GFR
- may have hematuria
- elevated Phos and potassium and Low Ca
- progressive metabolic acidosis
Underlying causes of AKI
-hypovolemia
-hypotension
-Reduced cardiac output and HF
-obstruction
Assessments and diagnostics of AKI
- BUN levels
- Creatine
- GFR
- US
- Non contrast CT
Prevention of AKI
- Monitor kidney function when giving nephrotoxic medications
- Contrast induced nephropathy (use mucomyst)
- Fluids
- Catheter care
Tx of AKI
- blood flow is restored to the kidneys with the use of IV fluids albumin and blood products
- maintaining fluid balance
- dialysis or RRT
- sodium bicarbonate to elevate PH levels
- Phosphate binding agents
- Kayexelate to reduce K+ levels
- IV dextrose 50%, insulin and Ca replacement to those who are hemodynamically unstable
- high carbohydrate feedings
Medical management of AKI
- monitor for hyperkalemia
- if the pt is experiencing EKG changes give 50% dextrose and insulin
- Medication dosages should be reduced
- monitor ABGs
- Weigh pt daily (if the pt gains or does not loose weight then fluid retention should be suspected)
Nutritional therapy CKD
low sodium, low potassium low phosphorus, moderate protein intake
End Stage Kidney Disease
5th stage of CKD, pt will require permanent renal replacement therapy
Complications of ESKD
Anemia
Bone disease
Hyperkalemia
HTN
Pericarditis
Pericardial effusion/tamponade
Vascular access device
Temporary dialysis catheter in the Subclavian vein, IntraJugular, or Femoral
the main type of vascular access devices for dialysis are
- arteriovenous fistulas
- arteriovenous grafts
- central venous catheters (there is cuffed vs non cuffed and cuffed has reduced chance of infection)
Renal function tests
- 24 Hour Urine/creatinine clearance (keep in dark container on ice)
- Creatinine level
- BUN
- GFR (should be >125)
Risk factors of chronic kidney disease
- cardiovascular disease
- diabetes
- hypertension
- obesity
Epogen
erythropoiesis-stimulating agent that is used to treat anemia in CKD
Periactin
Hemodialysis pre procedure
pt will need a patent vascular access point such as, an intra jugular CVC or an AV fistula
auscultate for bruit and palpate for a thrill
obtain vital signs, weight and labs prior to dialysis
Hemodialysis during and after the procedure
monitor for adverse effects such as hypotension, N/V, bleeding
after take pts weight and vitals (a decrease in weight and BP is expected) compare weight to estimate the amt of fluid removed
Peritoneal dialysis
instill hypertonic dialysate solution into the pts peritoneal cavity and allow it to dwell, then drain with the excess fluid and waste products
Peritoneal dialysis pre procedure
- warm dialysate solution
- assess pts weight
- sterile technique when accessing the catheter insertion site